Prebiotics: Definition, types, sources, mechanisms, and clinical applications

Foods

Volumn 8, Issue 3, 2019, Pages

  Davani Davari, Dorna ^a   Negahdaripour, Manica ^a,b   Karimzadeh, Iman ^a   Seifan, Mostafa ^c   Mohkam, Milad ^d   Masoumi, Seyed Jalil ^e   Berenjian, Aydin ^c   Ghasemi, Younes ^a,b,e,f  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF WAIKATO   (New Zealand)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fructo oligosaccharides; Galacto oligosaccharides; Gut microbiota; Prebiotics; Short chain fatty acids

Indexed keywords

EID: 85063289431     PISSN: None     EISSN: 23048158     Source Type: Journal    
DOI: 10.3390/foods8030092     Document Type: Review

References (207)

1. Collins, S.; Reid, G. Distant site effects of ingested prebiotics. Nutrients 2016, 8, 523. [CrossRef]
2. Louis, P.; Flint, H.J.; Michel, C. How to manipulate the microbiota: Prebiotics. In Microbiota of the Human Body; Springer: Basel, Switzerland, 2016; pp. 119-142.
3. Walker, A.W.; Ince, J.; Duncan, S.H.; Webster, L.M.; Holtrop, G.; Ze, X.; Brown, D.; Stares, M.D.; Scott, P.; Bergerat, A. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5, 220-230. [CrossRef]
4. Glenn, G.; Roberfroid, M. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995, 125, 1401-1412.
5. Gibson, G.R.; Probert, H.M.; Van Loo, J.; Rastall, R.A.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17, 259-275. [CrossRef] [PubMed]
6. Bouhnik, Y.; Raskine, L.; Simoneau, G.; Vicaut, E.; Neut, C.; Flourié, B.; Brouns, F.; Bornet, F.R. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am. J. Clin. Nutr. 2004, 80, 1658-1664. [CrossRef] [PubMed]
7. Flint, H.J.; Scott, K.P.; Louis, P.; Duncan, S.H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 577-589. [CrossRef] [PubMed]
8. Turroni, F.; Ventura, M.; Buttó, L.F.; Duranti, S.; O'Toole, P.W.; Motherway, M.O.C.; van Sinderen, D. Molecular dialogue between the human gut microbiota and the host: A lactobacillus and bifidobacterium perspective. Cell. Mol. Life Sci. 2014, 71, 183-203. [CrossRef]
9. Roberfroid, M. Health benefits of non-digestible oligosaccharides. In Dietary Fiber in Health and Disease; Springer: New York, NY, USA, 1997; pp. 211-219.
10. Morowvat, M.H.; Nezafat, N.; Ghasemi, Y.; Zare, M.H.; Mohkam, M. Probiotic potential of five lactobacillus strains isolated from traditional persian yoghurt in fars province, iran: Viewing through the window of phylogenetics. Biosci. Biotechnol. Res. Asia 2015, 12, 1265-1272.
11. Shokri, D.; Khorasgani, M.R.; Mohkam, M.; Fatemi, S.M.; Ghasemi, Y.; Taheri-Kafrani, A. The inhibition effect of lactobacilli against growth and biofilm formation of pseudomonas aeruginosa. Probiot. Antimicrob. Proteins 2018, 10, 34-42. [CrossRef]
12. Stinson, L.F.; Payne, M.S.; Keelan, J.A. Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota. Crit. Rev. Microbiol. 2017, 43, 352-369. [CrossRef]
13. Trompette, A.; Gollwitzer, E.S.; Yadava, K.; Sichelstiel, A.K.; Sprenger, N.; Ngom-Bru, C.; Blanchard, C.; Junt, T.; Nicod, L.P.; Harris, N.L.; et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 2014, 20, 159-166. [CrossRef] [PubMed]
14. Hernot, D.C.; Boileau, T.W.; Bauer, L.L.; Middelbos, I.S.; Murphy, M.R.; Swanson, K.S.; Fahey Jr, G.C. In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose. J. Agric. Food Chem. 2009, 57, 1354-1361. [CrossRef]
15. Zhou, Z.; Zhang, Y.; Zheng, P.; Chen, X.; Yang, Y. Starch structure modulates metabolic activity and gut microbiota profile. Anaerobe 2013, 24, 71-78. [CrossRef] [PubMed]
16. Clarke, T.B.; Davis, K.M.; Lysenko, E.S.; Zhou, A.Y.; Yu, Y.; Weiser, J.N. Recognition of peptidoglycan from the microbiota by nod1 enhances systemic innate immunity. Nat. Med. 2010, 16, 228-231. [CrossRef] [PubMed] 17. Hamer, H.M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F.; Brummer, R.J. Review article: The role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27, 104-119. [CrossRef] [PubMed]
17. den Besten, G.; van Eunen, K.; Groen, A.K.; Venema, K.; Reijngoud, D.-J.; Bakker, B.M. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 2013, 54, 2325-2340. [CrossRef] [PubMed]
18. Gibson, G.R.; Scott, K.P.; Rastall, R.A.; Tuohy, K.M.; Hotchkiss, A.; Dubert-Ferrandon, A.; Gareau, M.; Murphy, E.F.; Saulnier, D.; Loh, G.; et al. Dietary prebiotics: Current status and new definition. Food Sci. Technol. Bull. Funct. Foods 2010, 7, 1-19. [CrossRef]
19. Howlett, J.F.; Betteridge, V.A.; Champ, M.; Craig, S.A.; Meheust, A.; Jones, J.M. The definition of dietary fiber-discussions at the ninth vahouny fiber symposium: Building scientific agreement. Food Nutr. Res. 2010, 54, 5750. [CrossRef]
20. Slavin, J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 2013, 5, 1417-1435. [CrossRef]
21. Roberfroid, M.B. Prebiotics: Concept, definition, criteria, methodologies, and products. In Handbook of Prebiotics; CRC Press: Boca Raton, FL, USA, 2008; pp. 49-78.
22. Bindels, L.B.; Delzenne, N.M.; Cani, P.D.; Walter, J. Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 303-310. [CrossRef]
23. Scott, K.P.; Gratz, S.W.; Sheridan, P.O.; Flint, H.J.; Duncan, S.H. The influence of diet on the gut microbiota. Pharmacol. Res. 2013, 69, 52-60. [CrossRef]
24. Hutkins, R.W.; Krumbeck, J.A.; Bindels, L.B.; Cani, P.D.; Fahey, G.; Goh, Y.J.; Hamaker, B.; Martens, E.C.; Mills, D.A.; Rastal, R.A.; et al. Prebiotics: Why definitions matter. Curr. Opin. Biotechnol. 2016, 37, 1-7. [CrossRef] [PubMed]
25. Scott, K.P.; Martin, J.C.; Duncan, S.H.; Flint, H.J. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol. Ecol. 2014, 87, 30-40. [CrossRef] [PubMed]
26. Macfarlane, G.; Steed, H.; Macfarlane, S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol. 2008, 104, 305-344. [CrossRef] [PubMed]
27. Johnson, C.R.; Combs, G.F.; Thavarajah, P. Lentil (lens culinaris l.): A prebiotic-rich whole food legume. Food Res. Int. 2013, 51, 107-113. [CrossRef]
28. Whelan, K. Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders. Proc. Nutr. Soc. 2013, 72, 288-298. [CrossRef] [PubMed]
29. Fuentes-Zaragoza, E.; Sánchez-Zapata, E.; Sendra, E.; Sayas, E.; Navarro, C.; Fernández-López, J.; Pérez-Alvarez, J.A. Resistant starch as prebiotic: A review. Starch-Stärke 2011, 63, 406-415. [CrossRef]
30. Ze, X.; Duncan, S.H.; Louis, P.; Flint, H.J. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 2012, 6, 1535-1543. [CrossRef]
31. Costabile, A.; Fava, F.; Röytiö, H.; Forssten, S.D.; Olli, K.; Klievink, J.; Rowland, I.R.; Ouwehand, A.C.; Rastall, R.A.; Gibson, G.R.; et al. Impact of polydextrose on the faecal microbiota: A double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Br. J. Nutr. 2012, 108, 471-481. [CrossRef]
32. Yoo, H.-D.; Kim, D.-J.; Paek, S.-H.; Oh, S.-E. Plant cell wall polysaccharides as potential resources for the development of novel prebiotics. Biomol. Ther. 2012, 20, 371-379. [CrossRef]
33. Gullón, B.; Gómez, B.; Martínez-Sabajanes, M.; Yáñez, R.; Parajó, J.; Alonso, J. Pectic oligosaccharides: Manufacture and functional properties. Trends Food Sci. Technol. 2013, 30, 153-161. [CrossRef]
34. Tzounis, X.; Rodriguez-Mateos, A.; Vulevic, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am. J. Clin. Nutr. 2011, 93, 62-72. [CrossRef] [PubMed]
35. Varzakas, T.; Kandylis, P.; Dimitrellou, D.; Salamoura, C.; Zakynthinos, G.; Proestos, C. Innovative and fortified food: Probiotics, prebiotics, gmos, and superfood. In Preparation and Processing of Religious and Cultural Foods; Elsevier: London, UK, 2018; pp. 67-129.
36. Al-Sheraji, S.; Ismail, A.; Manap, M.; Mustafa, S.; Yusof, R.; Hassan, F. Prebiotics as functional foods: A review. J. Funct Foods 2013, 5, 1542-1553. [CrossRef]
37. Panesar, P.S.; Kumari, S.; Panesar, R. Biotechnological approaches for the production of prebiotics and their potential applications. Crit. Rev. Biotechnol. 2013, 33, 345-364. [CrossRef] [PubMed]
38. Havenaar, R.; Bonnin-Marol, S.; Van Dokkum, W.; Petitet, S.; Schaafsma, G. Inulin: Fermentation and microbial ecology in the intestinal tract. Food Rev. Int. 1999, 15, 109-120. [CrossRef]
39. Sangeetha, P.; Ramesh, M.; Prapulla, S. Recent trends in the microbial production, analysis and application of fructooligosaccharides. Trends Food Sci. Technol. 2005, 16, 442-457. [CrossRef]
40. Yun, J.W. Fructooligosaccharides-Occurrence, preparation, and application. Enzym. Microb. Technol. 1996, 19, 107-117. [CrossRef]
41. Prapulla, S.; Subhaprada, V.; Karanth, N. Microbial production of oligosaccharides: A review. Adv. Appl. Microbiol. 2000, 47, 299-343.
42. Barreteau, H.; Delattre, C.; Michaud, P. Production of oligosaccharides as promising new food additive generation. Food Technol. Biotechnol. 2006, 44, 323-333.
43. Caicedo, L.; Silva, E.; Sánchez, O. Semibatch and continuous fructooligosaccharides production by aspergillus sp. N74 in a mechanically agitated airlift reactor. J. Chem. Technol. Biotechnol. 2009, 84, 650-656. [CrossRef]
44. Sangeetha, P.; Ramesh, M.; Prapulla, S. Production of fructo-oligosaccharides by fructosyl transferase from aspergillus oryzae cfr 202 and aureobasidium pullulans cfr 77. Process Biochem. 2004, 39, 755-760. [CrossRef]
45. Mohkam, M.; Nezafat, N.; Berenjian, A.; Negahdaripour, M.; Behfar, A.; Ghasemi, Y. Role of bacillus genus in the production of value-added compounds. In Bacilli and Agrobiotechnology; Springer: Basel, Switzerland, 2016; pp. 1-33.
46. Chen, W.-C.; Liu, C.-H. Production of β-fructofuranosidase by aspergillus japonicus. Enzym. Microb. Technol. 1996, 18, 153-160. [CrossRef]
47. Prata, M.B.; Mussatto, S.I.; Rodrigues, L.R.; Teixeira, J.A. Fructooligosaccharide production by penicillium expansum. Biotechnol. Lett. 2010, 32, 837-840. [CrossRef]
48. Maiorano, A.E.; Piccoli, R.M.; Da Silva, E.S.; de Andrade Rodrigues, M.F. Microbial production of fructosyltransferases for synthesis of pre-biotics. Biotechnol. Lett. 2008, 30, 1867-1877. [CrossRef]
49. Mussatto, S.I.; Aguilar, C.N.; Rodrigues, L.R.; Teixeira, J.A. Fructooligosaccharides and β-fructofuranosidase production by aspergillus japonicus immobilized on lignocellulosic materials. J. Mol. Catal. B Enzym. 2009, 59, 76-81. [CrossRef]
50. Jong, W.Y.; Seung, K.S. The production of high-content fructo-oligosaccharides from sucrose by the mixed-enzyme system of fructosyltransferase and glucose oxidase. Biotechnol. Lett. 1993, 15, 573-576. [CrossRef]
51. Sheu, D.C.; Duan, K.J.; Cheng, C.Y.; Bi, J.L.; Chen, J.Y. Continuous production of high-content fructooligosaccharides by a complex cell system. Biotechnol. Prog. 2002, 18, 1282-1286. [CrossRef]
52. Yun, J.W.; Lee, M.G.; Song, S.K. Batch production of high-content fructo-oligosaccharides from sucrose by the mixed-enzyme system of β-fructofuranosidase and glucose oxidase. J. Ferment. Bioeng. 1994, 77, 159-163. [CrossRef]
53. Lin, T.-J.; Lee, Y.-C. High-content fructooligosaccharides production using two immobilized microorganisms in an internal-loop airlift bioreactor. J. Chin. Inst. Chem. Eng. 2008, 39, 211-217. [CrossRef]
54. Nishizawa, K.; Nakajima, M.; Nabetani, H. Kinetic study on transfructosylation by. Beta.-fructofuranosidase from aspergillus niger atcc 20611 and availability of a membrane reactor for fructooligosaccharide production. Food Sci. Technol. Res. 2001, 7, 39-44. [CrossRef]
55. Crittenden, R.; Playne, M. Purification of food-grade oligosaccharides using immobilised cells of zymomonas mobilis. Appl. Microbiol. Biotechnol. 2002, 58, 297-302.
56. Goulas, A.; Tzortzis, G.; Gibson, G.R. Development of a process for the production and purification of α-and β-galactooligosaccharides from bifidobacterium bifidum ncimb 41171. Int. Dairy J. 2007, 17, 648-656. [CrossRef]
57. Hernández, O.; Ruiz-Matute, A.I.; Olano, A.; Moreno, F.J.; Sanz, M.L. Comparison of fractionation techniques to obtain prebiotic galactooligosaccharides. Int. Dairy J. 2009, 19, 531-536. [CrossRef]
58. Yoon, S.-H.; Mukerjea, R.; Robyt, J.F. Specificity of yeast (saccharomyces cerevisiae) in removing carbohydrates by fermentation. Carbohydr. Res. 2003, 338, 1127-1132. [CrossRef]
59. Palcic, M.M. Biocatalytic synthesis of oligosaccharides. Curr. Opin. Biotechnol. 1999, 10, 616-624. [CrossRef]
60. Weijers, C.A.; Franssen, M.C.; Visser, G.M. Glycosyltransferase-catalyzed synthesis of bioactive oligosaccharides. Biotechnol. Adv. 2008, 26, 436-456. [CrossRef]
61. Koizumi, S.; Endo, T.; Tabata, K.; Ozaki, A. Large-scale production of udp-galactose and globotriose by coupling metabolically engineered bacteria. Nat. Biotechnol. 1998, 16, 847-850. [CrossRef]
62. 0 -fucosyllactose using recombinant bacterial enzymes. Carbohydr. Res. 2001, 334, 97-103. [CrossRef]
63. Priem, B.; Gilbert, M.; Wakarchuk, W.W.; Heyraud, A.; Samain, E. A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria. Glycobiology 2002, 12, 235-240. [CrossRef]
64. Monsan, P.; Paul, F. Enzymatic synthesis of oligosaccharides. FEMS Microbiol. Rev. 1995, 16, 187-192. [CrossRef]
65. Osman, A.; Tzortzis, G.; Rastall, R.A.; Charalampopoulos, D. Bbgiv is an important bifidobacterium β-galactosidase for the synthesis of prebiotic galactooligosaccharides at high temperatures. J. Agric. Food Chem. 2012, 60, 740-748. [CrossRef]
66. Prenosil, J.; Stuker, E.; Bourne, J. Formation of oligosaccharides during enzymatic lactose: Part i: State of art. Biotechnol. Bioeng. 1987, 30, 1019-1025. [CrossRef]
67. Rabiu, B.A.; Jay, A.J.; Gibson, G.R.; Rastall, R.A. Synthesis and fermentation properties of novel galacto-oligosaccharides by β-galactosidases frombifidobacterium species. Appl. Environ. Microbiol. 2001, 67, 2526-2530. [CrossRef]
68. Zarate, S.; Lopez-Leiva, M. Oligosaccharide formation during enzymatic lactose hydrolysis: A literature review. J. Food Prot. 1990, 53, 262-274. [CrossRef]
69. Neri, D.F.; Balcão, V.M.; Costa, R.S.; Rocha, I.C.; Ferreira, E.M.; Torres, D.P.; Rodrigues, L.R.; Carvalho, L.B.; Teixeira, J.A. Galacto-oligosaccharides production during lactose hydrolysis by free aspergillus oryzae β-galactosidase and immobilized on magnetic polysiloxane-polyvinyl alcohol. Food Chem. 2009, 115, 92-99. [CrossRef]
70. Iqbal, S.; Nguyen, T.-H.; Nguyen, T.T.; Maischberger, T.; Haltrich, D. B-galactosidase from lactobacillus plantarum wcfs1: Biochemical characterization and formation of prebiotic galacto-oligosaccharides. Carbohydr. Res. 2010, 345, 1408-1416. [CrossRef]
71. Iqbal, S.; Nguyen, T.-H.; Nguyen, H.A.; Nguyen, T.T.; Maischberger, T.; Kittl, R.; Haltrich, D. Characterization of a heterodimeric gh2 β-galactosidase from lactobacillus sakei lb790 and formation of prebiotic galacto-oligosaccharides. J. Agric. Food Chem. 2011, 59, 3803-3811. [CrossRef]
72. Yi, S.H.; Alli, I.; Park, K.H.; Lee, B. Overexpression and characterization of a novel transgalactosylic and hydrolytic β-galactosidase from a human isolate bifidobacterium breve b24. New Biotechnol. 2011, 28, 806-813. [CrossRef]
73. Fukuda, H.; Hama, S.; Tamalampudi, S.; Noda, H. Whole-cell biocatalysts for biodiesel fuel production. Trends Biotechnol. 2008, 26, 668-673. [CrossRef]
74. Burton, S.G.; Cowan, D.A.; Woodley, J.M. The search for the ideal biocatalyst. Nat. Biotechnol. 2002, 20, 37-45. [CrossRef]
75. Schmid, A.; Dordick, J.; Hauer, B.; Kiener, A.; Wubbolts, M.; Witholt, B. Industrial biocatalysis today and tomorrow. Nature 2001, 409, 258-268. [CrossRef] [PubMed]
76. Onishi, N.; Yokozeki, K. Gluco-oligosaccharide and galacto-oligosaccharide production by rhodotorula minuta ifo879. J. Ferment. Bioeng. 1996, 82, 124-127. [CrossRef]
77. Onishi, N.; Yamashiro, A.; Yokozeki, K. Production of galacto-oligosaccharide from lactose by sterigmatomyces elviae cbs8119. Appl. Environ. Microbiol. 1995, 61, 4022-4025. [PubMed]
78. Onishi, N.; Kira, I.; Yokozeki, K. Galacto-oligosaccharide production from lactose by sirobasidium magnum cbs6803. Lett. Appl. Microbiol. 1996, 23, 253-256. [CrossRef] [PubMed]
79. Onishi, N.; Tanaka, T. Purification and properties of a galacto-and gluco-oligosaccharide-producing β-glycosidase from rhodotorula minuta ifo879. J. Ferment. Bioeng. 1996, 82, 439-443. [CrossRef]
80. Onishi, N.; Tanaka, T. Purification and characterization of galacto-oligosaccharide-producing β-galactosidase from sirobasidium magnum. Lett. Appl. Microbiol. 1997, 24, 82-86. [CrossRef]
81. Li, Y.; Lu, L.; Wang, H.; Xu, X.; Xiao, M. Cell surface engineering of a β-galactosidase for galactooligosaccharide synthesis. Appl. Environ. Microbiol. 2009, 75, 5938-5942. [CrossRef] [PubMed]
82. Osman, A.; Tzortzis, G.; Rastall, R.A.; Charalampopoulos, D. A comprehensive investigation of the synthesis of prebiotic galactooligosaccharides by whole cells of bifidobacterium bifidum ncimb 41171. J. Biotechnol. 2010, 150, 140-148. [CrossRef] [PubMed]
83. Ji, E.-S.; Park, N.-H.; Oh, D.-K. Galacto-oligosaccharide production by a thermostable recombinant β-galactosidase from thermotoga maritima. World J. Microbiol. Biotechnol. 2005, 21, 759-764. [CrossRef]
84. Terpe, K. Overview of bacterial expression systems for heterologous protein production: From molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 2006, 72, 211-222. [CrossRef]
85. Demain, A.L.; Vaishnav, P. Production of recombinant proteins by microbes and higher organisms. Biotechnol. Adv. 2009, 27, 297-306. [CrossRef] [PubMed]
86. Yin, J.; Li, G.; Ren, X.; Herrler, G. Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J. Biotechnol. 2007, 127, 335-347. [CrossRef]
87. Porro, D.; Sauer, M.; Branduardi, P.; Mattanovich, D. Recombinant protein production in yeasts. Mol. Biotechnol. 2005, 31, 245-259. [CrossRef]
88. Buckholz, R.G.; Gleeson, M.A. Yeast systems for the commercial production of heterologous proteins. Nat. Biotechnol. 1991, 9, 1067-1072. [CrossRef]
89. Flint, H.J.; Duncan, S.H.; Scott, K.P.; Louis, P. Interactions and competition within the microbial community of the human colon: Links between diet and health. Environ. Microbiol. 2007, 9, 1101-1111. [CrossRef] [PubMed]
90. Cecchini, D.A.; Laville, E.; Laguerre, S.; Robe, P.; Leclerc, M.; Doré, J.; Henrissat, B.; Remaud-Siméon, M.; Monsan, P.; Potocki-Véronèse, G. Functional metagenomics reveals novel pathways of prebiotic breakdown by human gut bacteria. PLoS ONE 2013, 8, e72766. [CrossRef] [PubMed]
91. Belenguer, A.; Duncan, S.H.; Calder, A.G.; Holtrop, G.; Louis, P.; Lobley, G.E.; Flint, H.J. Two routes of metabolic cross-feeding between bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 2006, 72, 3593-3599. [CrossRef]
92. Ryan, S.M.; Fitzgerald, G.F.; van Sinderen, D. Screening for and identification of starch-, amylopectin-, and pullulan-degrading activities in bifidobacterial strains. Appl. Environ. Microbiol. 2006, 72, 5289-5296. [CrossRef]
93. Rossi, M.; Corradini, C.; Amaretti, A.; Nicolini, M.; Pompei, A.; Zanoni, S.; Matteuzzi, D. Fermentation of fructooligosaccharides and inulin by bifidobacteria: A comparative study of pure and fecal cultures. Appl. Environ. Microbiol. 2005, 71, 6150-6158. [CrossRef]
94. Falony, G.; Vlachou, A.; Verbrugghe, K.; De Vuyst, L. Cross-feeding between bifidobacterium longum bb536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl. Environ. Microbiol. 2006, 72, 7835-7841. [CrossRef]
95. Walker, A.W.; Duncan, S.H.; Leitch, E.C.M.; Child, M.W.; Flint, H.J. Ph and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 2005, 71, 3692-3700. [CrossRef]
96. Duncan, S.H.; Louis, P.; Thomson, J.M.; Flint, H.J. The role of ph in determining the species composition of the human colonic microbiota. Environ. Microbiol. 2009, 11, 2112-2122. [CrossRef] [PubMed]
97. Wilson, B.; Whelan, K. Prebiotic inulin-type fructans and galacto-oligosaccharides: Definition, specificity, function, and application in gastrointestinal disorders. J. Gastroenterol. Hepatol. 2017, 32, 64-68. [CrossRef] [PubMed]
98. Hunter, J.; Tuffnell, Q.; Lee, A. Controlled trial of oligofructose in the management of irritable bowel syndrome. J. Nutr. 1999, 129, 1451S-1453S. [CrossRef] [PubMed]
99. Olesen, M.; Gudmand-Høyer, E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am. J. Clin. Nutr. 2000, 72, 1570-1575. [CrossRef] [PubMed]
100. Paineau, D.; Payen, F.; Panserieu, S.; Coulombier, G.; Sobaszek, A.; Lartigau, I.; Brabet, M.; Galmiche, J.-P.; Tripodi, D.; Sacher-Huvelin, S.; et al. The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br. J. Nutr. 2008, 99, 311-318. [CrossRef] [PubMed]
101. Silk, D.; Davis, A.; Vulevic, J.; Tzortzis, G.; Gibson, G. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 2009, 29, 508-518. [CrossRef] [PubMed]
102. Lindsay, J.O.; Whelan, K.; Stagg, A.J.; Gobin, P.; Al-Hassi, H.O.; Rayment, N.; Kamm, M.; Knight, S.C.; Forbes, A. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with crohn's disease. Gut 2006, 55, 348-355. [CrossRef]
103. Benjamin, J.L.; Hedin, C.R.; Koutsoumpas, A.; Ng, S.C.; McCarthy, N.E.; Hart, A.L.; Kamm, M.A.; Sanderson, J.D.; Knight, S.C.; Forbes, A.; et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active crohn's disease. Gut 2011, 60, 923-929. [CrossRef]
104. Joossens, M.; De Preter, V.; Ballet, V.; Verbeke, K.; Rutgeerts, P.; Vermeire, S. Effect of oligofructose-enriched inulin (of-in) on bacterial composition and disease activity of patients with crohn's disease: Results from a double-blinded randomised controlled trial. Gut 2011, 61, 958. [CrossRef]
105. Candela, M.; Guidotti, M.; Fabbri, A.; Brigidi, P.; Franceschi, C.; Fiorentini, C. Human intestinal microbiota: Cross-talk with the host and its potential role in colorectal cancer. Crit. Rev. Microbiol. 2011, 37, 1-14. [CrossRef] [PubMed]
106. Louis, P.; Flint, H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 2009, 294, 1-8. [CrossRef] [PubMed]
107. Davis, C.D.; Milner, J.A. Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem. 2009, 20, 743-752. [CrossRef] [PubMed]
108. Pool-Zobel, B.L. Inulin-type fructans and reduction in colon cancer risk: Review of experimental and human data. Br. J. Nutr. 2005, 93, S73-S90. [CrossRef]
109. Rafter, J.; Bennett, M.; Caderni, G.; Clune, Y.; Hughes, R.; Karlsson, P.C.; Klinder, A.; O'Riordan, M.; O'Sullivan, G.C.; Pool-Zobel, B.; et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 2007, 85, 488-496. [CrossRef] [PubMed]
110. Patel, R.M.; Denning, P.W. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: What is the current evidence? Clin. Perinatol. 2013, 40, 11-25. [CrossRef] [PubMed]
111. Knol, J.; Boehm, G.; Lidestri, M.; Negretti, F.; Jelinek, J.; Agosti, M.; Stahl, B.; Marini, A.; Mosca, F. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr. 2005, 94, 31-33. [CrossRef]
112. Boehm, G.; Lidestri, M.; Casetta, P.; Jelinek, J.; Negretti, F.; Stahl, B.; Marini, A. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch. Dis. Childhood-Fetal Neonatal Ed. 2002, 86, F178-F181. [CrossRef]
113. Kapiki, A.; Costalos, C.; Oikonomidou, C.; Triantafyllidou, A.; Loukatou, E.; Pertrohilou, V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum. Dev. 2007, 83, 335-339. [CrossRef]
114. Indrio, F.; Riezzo, G.; Raimondi, F.; Bisceglia, M.; Cavallo, L.; Francavilla, R. Effects of probiotic and prebiotic on gastrointestinal motility in newborns. J. Physiol. Pharmacol. 2009, 60, 27-31.
115. Indrio, F.; Riezzo, G.; Raimondi, F.; Francavilla, R.; Montagna, O.; Valenzano, M.L.; Cavallo, L.; Boehm, G. Prebiotics improve gastric motility and gastric electrical activity in preterm newborns. J. Pediatr. Gastroenterol. Nutr. 2009, 49, 258-261. [CrossRef] [PubMed]
116. Labayen, I.; Forga, L.; Gonzalez, A.; Lenoir-Wijnkoop, I.; Martinez, J.A. Relationship between lactose digestion, gastrointestinal transit time and symptoms in lactose malabsorbers after dairy consumption. Aliment. Pharmacol. Ther. 2001, 15, 543-549. [CrossRef] [PubMed]
117. Srinivasjois, R.; Rao, S.; Patole, S. Prebiotic supplementation of formula in preterm neonates: A systematic review and meta-analysis of randomised controlled trials. Clin. Nutr. 2009, 28, 237-242. [CrossRef] [PubMed]
118. Klinder, A.; Gietl, E.; Hughes, R.; Jonkers, N.; Karlsson, P.; McGlyn, H.; Pistoli, S.; Tuohy, K.; Rafter, J.; Rowland, I.; et al. Gut fermentation products of insulin-derived prebiotics beneficially modulate markers of tumour progression in human colon tumour cells. Int. J. Cancer Prev. 2004, 1, 19-32.
119. Verghese, M.; Rao, D.; Chawan, C.; Shackelford, L. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature fisher 344 rats. J. Nutr. 2002, 132, 2804-2808. [CrossRef] [PubMed]
120. Denji, K.A.; Mansour, M.R.; Akrami, R.; Ghobadi, S.; Jafarpour, S.; Mirbeygi, S. Effect of dietary prebiotic mannan oligosaccharide (mos) on growth performance, intestinal microflora, body composition, haematological and blood serum biochemical parameters of rainbow trout (oncorhynchus mykiss) juveniles. J. Fish. Aquat. Sci. 2015, 10, 255.
121. Klatt, N.R.; Canary, L.A.; Sun, X.; Vinton, C.L.; Funderburg, N.T.; Morcock, D.R.; Quiñones, M.; Deming, C.B.; Perkins, M.; Hazuda, D.J.; et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in siv-infected macaques. J. Clin. Investig. 2013, 123, 903-907. [CrossRef]
122. Langen, L.V.; Mirjam, A.; Dieleman, L.A. Prebiotics in chronic intestinal inflammation. Inflamm. Bowel Dis. 2009, 15, 454-462. [CrossRef]
123. Steed, H.; Macfarlane, S. Mechanisms of prebiotic impact on health. In Prebiotics and Probiotics Science and Technology; Springer: New York, NY, USA, 2009; pp. 135-161.
124. Oyofo, B.; DeLoach, J.; Corrier, D.; Norman, J.; Ziprin, R.; Mollenhauer, H. Prevention of salmonella typhimurium colonization of broilers with d-mannose. Poult. Sci. 1989, 68, 1357-1360. [CrossRef]
125. Thorburn, A.N.; Macia, L.; Mackay, C.R. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 2014, 40, 833-842. [CrossRef]
126. Fujiwara, R.; Takemura, N.; Watanabe, J.; Sonoyama, K. Maternal consumption of fructo-oligosaccharide diminishes the severity of skin inflammation in offspring of nc/nga mice. Br. J. Nutr. 2010, 103, 530-538. [CrossRef]
127. Shadid, R.; Haarman, M.; Knol, J.; Theis, W.; Beermann, C.; Rjosk-Dendorfer, D.; Schendel, D.J.; Koletzko, B.V.; Krauss-Etschmann, S. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity-A randomized, double-blind, placebo-controlled study. Am. J. Clin. Nutr. 2007, 86, 1426-1437. [CrossRef] [PubMed]
128. Firmansyah, A.; Pramita, G.; Carrie Fassler, A.; Haschke, F.; Link-Amster, H. Improved humoral immune response to measles vaccine in infants receiving infant cereal with fructooligosaccharides. J. Pediatr. Gastroenterol. Nutr. 2001, 31, A521.
129. Langkamp-Henken, B.; Bender, B.S.; Gardner, E.M.; Herrlinger-Garcia, K.A.; Kelley, M.J.; Murasko, D.M.; Schaller, J.P.; Stechmiller, J.K.; Thomas, D.J.; Wood, S.M. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J. Am. Geriatr. Soc. 2004, 52, 3-12. [CrossRef] [PubMed]
130. Lomax, A.R.; Cheung, L.V.; Tuohy, K.M.; Noakes, P.S.; Miles, E.A.; Calder, P.C. B2-1 fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: Results from a randomised controlled trial. Br. J. Nutr. 2012, 108, 1818-1828. [CrossRef] [PubMed]
131. Saavedra, J.; Tschernia, A.; Moore, N.; Abi-Hanna, A.; Coletta, F.; Emenhiser, C.; Yolken, R. Gastro-intestinal function in infants consuming a weaning food supplemented with oligofructose, a prebiotic. J. Pediatr. Gastroenterol. Nutr. 1999, 29, 513. [CrossRef]
132. Tschernia, A.; Moore, N.; Abi-Hanna, A.; Yolken, R.; Coletta, F.; Emenhiser, C.; Saavedra, J. Effects of long-term consumption of a weaning food supplemented with oligofructose, a prebiotic, on general infant health status. J. Pediatr. Gastroenterol. Nutr. 1999, 29, 503. [CrossRef]
133. Clarke, S.; Green-Johnson, J.; Brooks, S.; Ramdath, D.; Bercik, P.; Avila, C.; Inglis, G.; Green, J.; Yanke, L.; Selinger, L. B2-1 fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: Results from a double-blinded, randomised, cross-over study in healthy adults. Br. J. Nutr. 2016, 115, 1748-1759. [CrossRef]
134. Lomax, A.R.; Cheung, L.V.; Noakes, P.S.; Miles, E.A.; Calder, P.C. Inulin-type β2-1 fructans have some effect on the antibody response to seasonal influenza vaccination in healthy middle-aged humans. Front. Immunol. 2015, 6, 490. [CrossRef]
135. Grüber, C.; van Stuijvenberg, M.; Mosca, F.; Moro, G.; Chirico, G.; Braegger, C.P.; Riedler, J.; Boehm, G.; Wahn, U.; MIPS 1 Working Group. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J. Allergy Clin. Immunol. 2010, 126, 791-797.
136. Moro, G.; Arslanoglu, S.; Stahl, B.; Jelinek, J.; Wahn, U.; Boehm, G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Childhood 2006, 91, 814-819. [CrossRef] [PubMed]
137. Guigoz, Y.; Rochat, F.; Perruisseau-Carrier, G.; Rochat, I.; Schiffrin, E. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. Nutr. Res. 2002, 22, 13-25. [CrossRef]
138. Vulevic, J.; Drakoularakou, A.; Yaqoob, P.; Tzortzis, G.; Gibson, G.R. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (b-gos) in healthy elderly volunteers. Am. J. Clin. Nutr. 2008, 88, 1438-1446. [PubMed]
139. Vulevic, J.; Juric, A.; Walton, G.E.; Claus, S.P.; Tzortzis, G.; Toward, R.E.; Gibson, G.R. Influence of galacto-oligosaccharide mixture (b-gos) on gut microbiota, immune parameters and metabonomics in elderly persons. Br. J. Nutr. 2015, 114, 586-595. [CrossRef] [PubMed]
140. Kukkonen, K.; Savilahti, E.; Haahtela, T.; Juntunen-Backman, K.; Korpela, R.; Poussa, T.; Tuure, T.; Kuitunen, M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119, 192-198. [CrossRef] [PubMed]
141. Gaman, A.; Kuo, B. Neuromodulatory processes of the brain-gut axis. Neuromodulation 2008, 11, 249-259. [CrossRef] [PubMed]
142. Mudd, A.T.; Alexander, L.S.; Berding, K.; Waworuntu, R.V.; Berg, B.M.; Donovan, S.M.; Dilger, R.N. Dietary prebiotics, milk fat globule membrane, and lactoferrin affects structural neurodevelopment in the young piglet. Front. Pediatr. 2016, 4, 4. [CrossRef]
143. Grenham, S.; Clarke, G.; Cryan, J.F.; Dinan, T.G. Brain-gut-microbe communication in health and disease. Front. Physiol. 2011, 2, 94. [CrossRef]
144. Liu, X.; Cao, S.; Zhang, X. Modulation of gut microbiota-brain axis by probiotics, prebiotics, and diet. J. Agric. Food Chem. 2015, 63, 7885-7895. [CrossRef]
145. Forsythe, P.; Bienenstock, J.; Kunze, W.A. Vagal pathways for microbiome-brain-gut axis communication. In Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease; Springer: New York, NY, USA, 2014; pp. 115-133.
146. Savignac, H.M.; Corona, G.; Mills, H.; Chen, L.; Spencer, J.P.; Tzortzis, G.; Burnet, P.W. Prebiotic feeding elevates central brain derived neurotrophic factor, n-methyl-d-aspartate receptor subunits and d-serine. Neurochem. Int. 2013, 63, 756-764. [CrossRef]
147. Williams, S.; Chen, L.; Savignac, H.M.; Tzortzis, G.; Anthony, D.C.; Burnet, P.W. Neonatal prebiotic (bgos) supplementation increases the levels of synaptophysin, glun2a-subunits and bdnf proteins in the adult rat hippocampus. Synapse 2016, 70, 121-124. [CrossRef] [PubMed]
148. Sudo, N.; Chida, Y.; Aiba, Y.; Sonoda, J.; Oyama, N.; Yu, X.N.; Kubo, C.; Koga, Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 2004, 558, 263-275. [CrossRef] [PubMed]
149. Heijtz, R.D.; Wang, S.; Anuar, F.; Qian, Y.; Björkholm, B.; Samuelsson, A.; Hibberd, M.L.; Forssberg, H.; Pettersson, S. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA 2011, 108, 3047-3052. [CrossRef] [PubMed]
150. Neufeld, K.; Kang, N.; Bienenstock, J.; Foster, J. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 2011, 23, 255-e119. [CrossRef] [PubMed]
151. Nelson, E.D.; Ramberg, J.E.; Best, T.; Sinnott, R.A. Neurologic effects of exogenous saccharides: A review of controlled human, animal, and in vitro studies. Nutr. Neurosci. 2012, 15, 149-162. [CrossRef] [PubMed]
152. Best, T.; Howe, P.; Bryan, J.; Buckley, J.; Scholey, A. Acute effects of a dietary non-starch polysaccharide supplement on cognitive performance in healthy middle-aged adults. Nutr. Neurosci. 2015, 18, 76-86. [CrossRef] [PubMed]
153. Best, T.; Kemps, E.; Bryan, J. Saccharide effects on cognition and well-being in middle-aged adults: A randomized controlled trial. Dev. Neuropsychol. 2009, 35, 66-80. [CrossRef]
154. Han, H.S.; Jang, J.-H.; Jang, J.H.; Choi, J.S.; Kim, Y.J.; Lee, C.; Lim, S.H.; Lee, H.-K.; Lee, J. Water extract of triticum aestivum l. And its components demonstrate protective effect in a model of vascular dementia. J. Med. Food 2010, 13, 572-578. [CrossRef]
155. Schmidt, K.; Cowen, P.J.; Harmer, C.J.; Tzortzis, G.; Errington, S.; Burnet, P.W. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 2015, 232, 1793-1801. [CrossRef]
156. van den Berg, J.P.; Westerbeek, E.; Bröring-Starre, T.; Garssen, J.; van Elburg, R.M. Neurodevelopment of preterm infants at 24 month after neonatal supplementation of a prebiotic mix: A randomized trial. J. Pediatr. Gastroenterol. Nutr. 2016, 63, 270-276. [CrossRef]
157. Smith, A.P.; Sutherland, D.; Hewlett, P. An investigation of the acute effects of oligofructose-enriched inulin on subjective wellbeing, mood and cognitive performance. Nutrients 2015, 7, 8887-8896. [CrossRef] [PubMed]
158. Smith, A.P. The concept of well-being: Relevance to nutrition research. Br. J. Nutr. 2005, 93, S1-S5. [CrossRef] [PubMed]
159. Waworuntu, R.; Hain, H.; Chang, Q.; Thiede, L.; Hanania, T.; Berg, B. Dietary prebiotics improve memory and social interactions while reducing anxiety when provided early in life to normally developing rodents (637.5). FASEB J. 2014, 28, 637.5.
160. Messaoudi, M.; Rozan, P.; Nejdi, A.; Hidalgo, S.; Desor, D. Behavioural and cognitive effects of oligofructose-enriched inulin in rats. Br. J. Nutr. 2005, 93, S27-S30. [CrossRef] [PubMed]
161. Buie, T.; Campbell, D.B.; Fuchs, G.J.; Furuta, G.T.; Levy, J.; VandeWater, J.; Whitaker, A.H.; Atkins, D.; Bauman, M.L.; Beaudet, A.L.; et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with asds: A consensus report. Pediatrics 2010, 125, S1-S8. [CrossRef] [PubMed]
162. Adams, J.B.; Johansen, L.J.; Powell, L.D.; Quig, D.; Rubin, R.A. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011, 11, 22. [CrossRef] [PubMed]
163. Navarro, F.; Liu, Y.; Rhoads, J.M. Can probiotics benefit children with autism spectrum disorders? World J. Gastroenterol. 2016, 22, 10093. [CrossRef]
164. De Angelis, M.; Piccolo, M.; Vannini, L.; Siragusa, S.; De Giacomo, A.; Serrazzanetti, D.I.; Cristofori, F.; Guerzoni, M.E.; Gobbetti, M.; Francavilla, R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE 2013, 8, e76993. [CrossRef]
165. ® , a soluble fibre with prebiotic properties, may be beneficial for health. J. Int. Med. Res. 2012, 40, 211-224. [CrossRef]
166. Nankova, B.B.; Agarwal, R.; MacFabe, D.F.; La Gamma, E.F. Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including creb-dependent catecholaminergic neurotransmission, in pc12 cells-possible relevance to autism spectrum disorders. PLoS ONE 2014, 9, e103740. [CrossRef]
167. Müller, J.B.; Guggenheim, P.; Haemmerli, U. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1966, 287, 890-893. [CrossRef]
168. Prasad, S.; Dhiman, R.K.; Duseja, A.; Chawla, Y.K.; Sharma, A.; Agarwal, R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007, 45, 549-559. [CrossRef] [PubMed]
169. Shukla, S.; Shukla, A.; Mehboob, S.; Guha, S. Meta-analysis: The effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment. Pharmacol. Ther. 2011, 33, 662-671. [CrossRef] [PubMed]
170. Elkington, S.; Floch, M.; Conn, H. Lactulose in the treatment of chronic portal-systemic encephalopathy: A double-blind clinical trial. N. Engl. J. Med. 1969, 281, 408-412. [CrossRef] [PubMed]
171. Blanc, P.; Daures, J.P.; Rouillon, J.M.; Peray, P.; Pierrugues, R.; Larrey, D.; Gremy, F.; Michel, H. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: Results of a meta-analysis. Hepatology 1992, 15, 222-228. [CrossRef] [PubMed]
172. Cammà, C.; Fiorello, F.; Tinè, F.; Marchesini, G.; Fabbri, A.; Pagliaro, L. Lactitol in treatment of chronic hepatic encephalopathy. Digest. Dis. Sci. 1993, 38, 916-922. [CrossRef] [PubMed]
173. Weber, F., Jr. Lactulose and combination therapy of hepatic encephalopathy: The role of the intestinal microflora. Digest. Dis. 1996, 14, 53-63. [CrossRef]
174. Hong, K.-B.; Jeong, M.; Han, K.S.; Hwan Kim, J.; Park, Y.; Suh, H.J. Photoprotective effects of galacto-oligosaccharide and/or bifidobacterium longum supplementation against skin damage induced by ultraviolet irradiation in hairless mice. Int. J. Food Sci. Nutr. 2015, 66, 923-930. [CrossRef]
175. Kawakami, K.; Makino, I.; Asahara, T.; Kato, I.; Onoue, M. Dietary galacto-oligosaccharides mixture can suppress serum phenol and p-cresol levels in rats fed tyrosine diet. J. Nutr. Sci. Vitaminol. 2005, 51, 182-186. [CrossRef]
176. Mitsuyoshi, K.; Masuoka, N.; Chiaki, K.; Sugimoto, S.; Iizuka, R.; Manabe, K.; Toshiro, S.; Kazutoshi, O.; Nonaka, C.; Miyazaki, K.; et al. Consecutive intake of fermented milk containing bifidobacterium breve strain yakult and galacto-oligosaccharides benefits skin condition in healthy adult women. Biosci. Microbiot. Food Health 2013, 32, 33-39.
177. Miyazaki, K.; Masuoka, N.; Kano, M.; Iizuka, R. Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. Benef. Microbes 2013, 5, 121-128. [CrossRef] [PubMed]
178. Mohkam, M.; Nezafat, N.; Berenjian, A.; Mobasher, M.A.; Ghasemi, Y. Identification of bacillus probiotics isolated from soil rhizosphere using 16s rrna, reca, rpob gene sequencing and rapd-pcr. Probiot. Antimicrob. Proteins 2016, 8, 8-18. [CrossRef] [PubMed]
179. Mohkam, M.; Rasoul-Amini, S.; Shokri, D.; Berenjian, A.; Rahimi, F.; Sadraeian, M.; Khalvati, B.; Gholami, A.; Ghasemi, Y. Characterization and in vitro probiotic assessment of potential indigenous bacillus strains isolated from soil rhizosphere. Minerva Biotechnol. 2016, 28, 19-28.
180. Mozaffarian, D.; Benjamin, E.; Go, A.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; Das, S.R.; Sarah de Ferranti, M.; Després, J.-P.; Fullerton, H.J.; et al. Aha statistical update. Heart Dis. Stroke 2015, 131, 29-322.
181. Letexier, D.; Diraison, F.; Beylot, M. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am. J. Clin. Nutr. 2003, 77, 559-564. [CrossRef] [PubMed]
182. Russo, F.; Chimienti, G.; Riezzo, G.; Pepe, G.; Petrosillo, G.; Chiloiro, M.; Marconi, E. Inulin-enriched pasta affects lipid profile and lp (a) concentrations in italian young healthy male volunteers. Eur. J. Nutr. 2008, 47, 453-459. [CrossRef]
183. Forcheron, F.; Beylot, M. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 2007, 56, 1093-1098. [CrossRef]
184. Vogt, J.A.; Ishii-Schrade, K.B.; Pencharz, P.B.; Jones, P.J.; Wolever, T.M. L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. J. Nutr. 2006, 136, 2160-2166. [CrossRef]
185. Jenkins, D.; Wolever, T.; Jenkins, A.; Brighenti, F.; Vuksan, V.; Rao, A.V.; Cunnane, S.C.; Ocana, A.; Corey, P.; Vezina, C. Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. Am. J. Clin. Nutr. 1991, 54, 141-147. [CrossRef]
186. Vulevic, J.; Juric, A.; Tzortzis, G.; Gibson, G.R. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 2013, 143, 324-331. [CrossRef]
187. Tiwari, U.; Cummins, E. Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels. Nutrition 2011, 27, 1008-1016. [CrossRef] [PubMed]
188. Brighenti, F. Dietary fructans and serum triacylglycerols: A meta-analysis of randomized controlled trials. J. Nutr. 2007, 137, 2552S-2556S. [CrossRef] [PubMed]
189. Beynen, A.C.; Buechler, K.F.; Van der Molen, A.J.; Geelen, M.J. The effects of lactate and acetate on fatty acid and cholesterol biosynthesis by isolated rat hepatocytes. Int. J. Biochem. 1982, 14, 165-169. [CrossRef]
190. Wolever, T.; Brighenti, F.; Royall, D.; Jenkins, A.L.; Jenkins, D.J. Effect of rectal infusion of short chain fatty acids in human subjects. Am. J. Gastroenterol. 1989, 84, 1027-1033. [PubMed]
191. Wolever, T.; Spadafora, P.J.; Cunnane, S.C.; Pencharz, P.B. Propionate inhibits incorporation of colonic [1, 2-13c] acetate into plasma lipids in humans. Am. J. Clin. Nutr. 1995, 61, 1241-1247. [CrossRef] [PubMed]
192. Mortensen, P.B.; Holtug, K.; Rasmussen, H.S. Short-chain fatty acid production from mono-and disaccharides in a fecal incubation system: Implications for colonic fermentation of dietary fiber in humans. J. Nutr. 1988, 118, 321-325. [CrossRef] [PubMed]
193. Lambert, J.E.; Parnell, J.A.; Eksteen, B.; Raman, M.; Bomhof, M.R.; Rioux, K.P.; Madsen, K.L.; Reimer, R.A. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: A randomized controlled trial protocol. BMC Gastroenterol. 2015, 15, 169. [CrossRef] [PubMed]
194. Tarantino, G.; Finelli, C. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. Future Microbiol. 2015, 10, 889-902. [CrossRef]
195. Cashman, K. Calcium intake, calcium bioavailability and bone health. Br. J. Nutr. 2002, 87, S169-S177. [CrossRef]
196. Carlson, J.L.; Erickson, J.M.; Lloyd, B.B.; Slavin, J.L. Health effects and sources of prebiotic dietary fiber. Curr. Dev. Nutr. 2018, 2, nzy005. [CrossRef]
197. Ellegård, L.; Andersson, H.; Bosaeus, I. Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, ca, mg, zn, fe, or bile acids but increases energy excretion in ileostomy subjects. Eur. J. Clin. Nutr. 1997, 51, 1-5. [CrossRef] [PubMed]
198. Van den Heuvel, E.; Schaafsma, G.; Muys, T.; van Dokkum, W. Nondigestible oligosaccharides do not interfere with calcium and nonheme-iron absorption in young, healthy men. Am. J. Clin. Nutr. 1998, 67, 445-451. [CrossRef] [PubMed]
199. Tahiri, M.; Tressol, J.C.; Arnaud, J.; Bornet, F.R.; Bouteloup-Demange, C.; Feillet-Coudray, C.; Brandolini, M.; Ducros, V.; Pépin, D.; Brouns, F.; et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: A stable-isotope study. Am. J. Clin. Nutr. 2003, 77, 449-457. [CrossRef] [PubMed]
200. López-Huertas, E.; Teucher, B.; Boza, J.J.; Martínez-Férez, A.; Majsak-Newman, G.; Baró, L.; Carrero, J.J.; González-Santiago, M.; Fonollá, J.; Fairweather-Tait, S. Absorption of calcium from milks enriched with fructo-oligosaccharides, caseinophosphopeptides, tricalcium phosphate, and milk solids. Am. J. Clin. Nutr. 2006, 83, 310-316. [CrossRef] [PubMed]
201. Van Den Heuvel, E.G.; Muijs, T.; Van Dokkum, W.; Schaafsma, G. Lactulose stimulates calcium absorption in postmenopausal women. J. Bone Miner. Res. 1999, 14, 1211-1216. [CrossRef] [PubMed]
202. van den Heuvel, E.G.; Schoterman, M.H.; Muijs, T. Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J. Nutr. 2000, 130, 2938-2942. [CrossRef] [PubMed]
203. Abrams, S.A.; Griffin, I.J.; Hawthorne, K.M.; Liang, L.; Gunn, S.K.; Darlington, G.; Ellis, K.J. A combination of prebiotic short-and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am. J. Clin. Nutr. 2005, 82, 471-476. [CrossRef]
204. Griffin, I.; Davila, P.; Abrams, S. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br. J. Nutr. 2002, 87, S187-S191. [CrossRef]
205. Svensson, U.; Håkansson, J. Safety of Food and Beverages: Safety of Probiotics and Prebiotics; Elsevier: New York, NY, USA, 2014.
206. Garg, B.D.; Balasubramanian, H.; Kabra, N.S. Physiological effects of prebiotics and its role in prevention of necrotizing enterocolitis in preterm neonates. J. Matern.-Fetal Neonatal Med. 2018, 31, 2071-2078. [CrossRef]
207. Tsai, Y.-L.; Lin, T.-L.; Chang, C.-J.; Wu, T.-R.; Lai, W.-F.; Lu, C.-C.; Lai, H.-C. Probiotics, prebiotics and amelioration of diseases. J. Biomed. Sci. 2019, 26, 3. [CrossRef]